Enter at least 4 characters

1 results showing for: 'nonacog gamma, [recombinant factor ix]'

[Xpharm]
  • Inj 500 iu vial
    • Brand Fully subsidised brand. RIXUBIS
    • Pharmacode2487942
    • Subsidy $435.00
    • Measure / Qty per 1
    (RIXUBIS Inj 500 iu vial to be delisted 01 February 2025)
  • Inj 1,000 iu vial
    • Brand Fully subsidised brand. RIXUBIS
    • Pharmacode2487896
    • Subsidy $870.00
    • Measure / Qty per 1
  • Inj 2,000 iu vial
    • Brand Fully subsidised brand. RIXUBIS
    • Pharmacode2487950
    • Subsidy $1740.00
    • Measure / Qty per 1
  • Inj 3,000 iu vial
    • Brand Fully subsidised brand. RIXUBIS
    • Pharmacode2487918
    • Subsidy $2610.00
    • Measure / Qty per 1

For patients with haemophilia. Access to funded treatment is managed by the Haemophilia Treaters Group in conjunction with the National Haemophilia Management Group.

  • Rectangle page icon symoblising a PDF. PDF
  • A tick icon. Fully subsidised
  • An oval with the number 29 in it. Unapproved medicine under Section 29
  • An asterisk symbol. 3 or 6 months should be dispensed at once
  • Two duplicate pages icon. Click to copy
  • A triangle symbol. Three months supply may be dispensed at one time if endorsed "certified exemption" by the prescriber or pharmacist.
  • OP Original pack
  • Sole Subsidised Supply